OSIVAX
  • COMPANY
    • ABOUT US
    • EXECUTIVE COMMITTEE
    • SCIENTIFIC ADVISORY BOARD
    • CLINICAL ADVISORY BOARD
    • BOARD OF DIRECTORS
    • PARTNERS
  • SCIENCE
  • PIPELINE
    • OVERVIEW
    • INFLUENZA - OVX836
    • CORONAVIRUS
  • NEWS
    • PRESS RELEASES
    • MEDIA COVERAGE
    • PUBLICATIONS
    • EVENTS
  • CONTACT
    • CAREERS >
      • Analyste Business Development
      • Technicien R&D (H/F) Poste en CDD de 6 mois, basé à Lyon (69)
    • LEGAL MENTIONS
EXECUTIVE COMMITTEE
Picture




Dr. Delphine GUYON-GELLIN, DVM
Chief Business Development Officer

Delphine has a strong background in strategic consulting, working with leading pharmaceutical companies
to help them solve their key challenges, along with an in-depth expertise in strategy for vaccines
​
Prior experience:
  • Project leader, Boston Consulting Group, London (2014-2017)
  • Senior Consultant, Boston Consulting Group, Paris (2011-2014)
  • Junior Consultant, AEC Partners, Paris (2007-2011)

Education:
  • Doctor of Veterinary Medicine, Ecole Vétérinaire de Maisons-Alfort
  • Master Degree, HEC, Paris
return
Proudly powered by Weebly
  • COMPANY
    • ABOUT US
    • EXECUTIVE COMMITTEE
    • SCIENTIFIC ADVISORY BOARD
    • CLINICAL ADVISORY BOARD
    • BOARD OF DIRECTORS
    • PARTNERS
  • SCIENCE
  • PIPELINE
    • OVERVIEW
    • INFLUENZA - OVX836
    • CORONAVIRUS
  • NEWS
    • PRESS RELEASES
    • MEDIA COVERAGE
    • PUBLICATIONS
    • EVENTS
  • CONTACT
    • CAREERS >
      • Analyste Business Development
      • Technicien R&D (H/F) Poste en CDD de 6 mois, basé à Lyon (69)
    • LEGAL MENTIONS